CIP
AMED

Chartwell Investment Partners’s Amedisys AMED Stock Holding History

Chartwell Investment Partners’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-11,086
Closed -$1.07M – 407
2022
Q3 		$1.07M Buy
+11,086
New +$1.32M 0.05% 343
2017
Q1 		– Sell
-75,800
Closed -$3.23M – 407
2016
Q4 		$3.23M Sell
75,800
-24,020
-24% -$1.02M 0.11% 262
2016
Q3 		$4.74M Buy
+99,820
New +$4.98M 0.08% 262

Other funds holding AMED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Chartwell Investment Partners's AMED Position: Q4 2022 in Review

Chartwell Investment Partners sold out of Amedisys (AMED) in Q4 2022, closing a stake of 11,086 shares — an estimated $1.07M sold.

Chartwell Investment Partners first reported a position in AMED in Q3 2016 and held it in 3 quarters. The position peaked at $4.74M in Q3 2016. 277 funds tracked by Wall St. Rank hold AMED as of Q4 2022.

  • Chartwell Investment Partners reported no remaining Amedisys position as of Q4 2022 after selling out during the quarter.
  • Chartwell Investment Partners sold 11,086 Amedisys shares in Q4 2022, an estimated $1.07M.
  • Chartwell Investment Partners first reported a position in Amedisys in Q3 2016 and held it in 3 quarters.
  • Chartwell Investment Partners's Amedisys position peaked at $4.74M in Q3 2016.
  • 277 funds tracked by Wall St. Rank held Amedisys as of Q4 2022.

Based on Chartwell Investment Partners's 13F filing for Q4 2022, filed 16 Feb 2023.